ABIVAX Société Anonyme

ABIVAX Société Anonymeverified

ABVX.PA

Price:

$10.48

Market Cap:

$663.02M

ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengu...[Read more]

Industry

Biotechnology

IPO Date

2015-06-26

Stock Exchange

EURONEXT

Ticker

ABVX.PA

The ROE as of September 2024 (TTM) for ABIVAX Société Anonyme (ABVX.PA) is -106.86%

According to ABIVAX Société Anonyme’s latest financial reports and current stock price. The company's current ROE is -106.86%. This represents a change of -125.51% compared to the average of 418.89% of the last 4 quarters.

ABIVAX Société Anonyme (ABVX.PA) Historical ROE (quarterly & annually)

How has ABVX.PA ROE performed in the past?

The mean historical ROE of ABIVAX Société Anonyme over the last ten years is -513.43%. The current -106.86% ROE has changed -79.19% with respect to the historical average. Over the past ten years (40 quarters), ABVX.PA's ROE was at its highest in in the June 2022 quarter at 3.93%. The ROE was at its lowest in in the December 2022 quarter at -2140.97%.

Quarterly (TTM)
Annual

Average

-513.43%

Median

-60.52%

Minimum

-3711.26%

Maximum

-22.24%

ABIVAX Société Anonyme (ABVX.PA) ROE by Quarter and Year

Discovering the peaks and valleys of ABIVAX Société Anonyme ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.48%

Maximum Annual ROE = -22.24%

Minimum Annual Increase = -97.97%

Minimum Annual ROE = -3711.26%

Quarterly (TTM)
Annual
YearROEChange
2023-75.37%-97.97%
2022-3711.26%2.48%
2021-143.73%-82.11%
2020-803.57%209.03%
2019-260.03%469.49%
2018-45.66%96.03%
2017-23.29%-7.67%
2016-25.23%13.43%
2015-22.24%-6.82%
2014-23.87%37.77%

ABIVAX Société Anonyme (ABVX.PA) Average ROE

How has ABVX.PA ROE performed in the past?

The current ROE of ABIVAX Société Anonyme (ABVX.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1310.12%

5-year avg

-998.79%

10-year avg

-513.43%

ABIVAX Société Anonyme (ABVX.PA) ROE vs. Peers

How is ABVX.PA’s ROE compared to its peers?

ABIVAX Société Anonyme’s ROE is greater than ERYTECH Pharma S.A. (-104.14%), less than GenSight Biologics S.A. (136.12%), greater than Innate Pharma S.A. (-20.69%), less than Poxel S.A. (125.30%), less than Nanobiotix S.A. (142.74%),

CompanyROEMarket cap
-104.14%$48.66M
136.12%$41.64M
-20.69%$165.95M
125.30%$29.32M
142.74%$218.88M

Build a custom stock screener for ABIVAX Société Anonyme (ABVX.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ABIVAX Société Anonyme using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ABIVAX Société Anonyme (ABVX.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ABIVAX Société Anonyme or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is ABIVAX Société Anonyme's ROE?

How is the ROE calculated for ABIVAX Société Anonyme (ABVX.PA)?

What is the highest ROE for ABIVAX Société Anonyme (ABVX.PA)?

What is the 3-year average ROE for ABIVAX Société Anonyme (ABVX.PA)?

What is the 5-year average ROE for ABIVAX Société Anonyme (ABVX.PA)?

How does the current ROE for ABIVAX Société Anonyme (ABVX.PA) compare to its historical average?